Glioblastoma Multiforme Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 17
SKU : PH2127
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Glioblastoma Multiforme Market?
Glioblastoma Multiforme Market is expected to grow at a CAGR of 8.6% during the forecast period 2024-2031.
Who are the Key Players of Glioblastoma Multiforme Market ?
The key players operating in the global glioblastoma multiforme market are Genentech, Amgen, Merck & Co., Inc., Teva Pharmaceutical Industries, Ltd., Arbor Pharmaceuticals LLC., Sun Pharmaceutical Industries, Ltd., F. Hoffmann-Le Roche AG, Novartis, and Pfizer.
Related Reports
pharmaceuticalsGlioblastoma Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 23
Starting from
$4350
medical-devicesMultiparameter Patient Monitoring Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 27
Starting from
$4350
energy-and-powerDigital Multimeter Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 24
Starting from
$4350
clinical-diagnosticsMultiplexed Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 27
Starting from
$4350
medical-imagingMultimodal Imaging Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 29
Starting from
$4350
medical-devicesMultimodal Biometric Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 17
Starting from
$4350